UNSPSC 51342501: Abacavir

This classification denotes a reverse transcriptase inhibitor with the molecular formula C14H18N6O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WR2TIP26VS, chemically known as 2-cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-, (1s-cis)- but generally known as abacavir, which bears US NIH Compound Identifier 65140. Abacavir most often appears in forms succinate and sulfate, and is sometimes combined with lamivudine and zidovudine.

UNSPSC 51342501 Abacavir, a Commodity code, nominally identifies antiretroviral pharmaceutical products, but recent state and local opportunities show no actual solicitation activity for abacavir or HIV treatment drugs under this code. Instead, the opportunities posted against 51342501 span emergency medical supplies, naloxone kits, generic pharmaceuticals, and over-the-counter products—a fundamental mismatch between the code's stated scope and what state and local governments are actually buying. The issuing bodies include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota MMCAP), indicating that health-related procurement spans diverse local jurisdictions and regional group-purchasing organizations. The work being solicited covers emergency responder supplies, first-aid consumables, generic drug distribution networks, and direct-to-manufacturer pharmacy program development, none of which relates to abacavir procurement.

Geographic activity appears concentrated in Florida and Minnesota, with Texas participation through its HHS Commission's exploratory pharmacy initiative. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, response due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually to support community health initiatives. The City of Tampa released ITB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first-aid supplies including respiratory equipment, cardiac electrodes, and consumables for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a SLBE set-aside designation offering a 5 percent bid discount. Minnesota MMCAP issued RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026. Texas HHS posted RFI HHS0017013 (posted April 3, 2026) to gather vendor capabilities for a direct-to-manufacturer prescription program outside traditional pharmacy benefit manager relationships. This code shows minimal genuine abacavir procurement activity and does not reflect current state and local buying patterns for antiretroviral drugs.